Authors/Disclosures
|
John Winkelman, MD, PhD
|
John Winkelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexza. John Winkelman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Azurity. John Winkelman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Disc Medicine. An immediate family member of John Winkelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Emalex. John Winkelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentec. John Winkelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Haleon. John Winkelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. John Winkelman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Noctrix. John Winkelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Psychogenics. The institution of John Winkelman has received research support from American Regent. The institution of John Winkelman has received research support from Merck. John Winkelman has received publishing royalties from a publication relating to health care. John Winkelman has a non-compensated relationship as a Chair with International Restless Legs Syndrome Study Group that is relevant to AAN interests or activities. John Winkelman has a non-compensated relationship as a Member with Restless Legs Syndrome Foundation Scientific Medical Advisory Board that is relevant to AAN interests or activities. |
|
Veeresh Kumar Nanjangud Shivamurthy, MBBS
|
No disclosure on file |
|
Kapil D. Sethi, MD, FRCP (UK), FAAN
|
Dr. Sethi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. |
|
Abdul Rahman Alchaki, MD
(Houston Methodist)
|
Dr. Alchaki has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. |
|
Clete A. Kushida, MD, PhD
(Stanford Sleep Medicine Center)
|
Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avadel. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Kushida has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for XW Pharma, Inc.. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zephyr Sleep Technologies. Dr. Kushida has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vivos. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerebra. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck & Co., Inc.. Dr. Kushida has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for State of Arizona. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Browne George Ross, LLP. The institution of Dr. Kushida has received research support from AmCAD, Philips-Respironics, Asate, Syneos Health, Inspire. Dr. Kushida has received publishing royalties from a publication relating to health care. |
|
Nidhiben A. Anadani, MD
(University Of Oklahoma Health Science Center)
|
Dr. Anadani has nothing to disclose. |
|
Sarah Brittain, MS CCC SLP
(Colorado Concussion Clinic)
|
No disclosure on file |
|
|
No disclosure on file |
|
Machteld E. Hillen, MD, FAAN
(Rutgers-NJMS)
|
The institution of Dr. Hillen has received research support from Genentech. |
|
|
No disclosure on file |
|
James J. Cappola, MD, PhD
(UCB Schwarz Biosciences)
|
No disclosure on file |
|
Juergen Reess, MD
(Boehringer Ingelheim Pharma GmbH & Co, KG)
|
No disclosure on file |